title: Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study.
abstract: OBJECTIVE
  The aim of our study was to examine the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) treatment on depressive symptoms, changes in bleeding patterns, and quality of life (QoL) among premenopausal women in our clinic.
  
  
  METHODS
  We recruited 120 premenopausal women, aged 18-50 years, who had sought care in the previous year for menorrhagia. LNG-IUS was inserted into eligible patients after the relevant evaluations. Both questionnaires were administered at time of the initial screening before and 6 months after insertion of the LNG-IUS. All patients completed the 36-item Short-Form Health Survey (SF-36) for QoL and Beck's Depression Inventory for depressive symptoms.
  
  
  RESULTS
  At the 6-month follow-up visit, the pictorial blood assessment chart score (PBAC) considerably decreased (p < 0.001). For SF-36 scores, physical functioning, physical role limitations, emotional role limitations, bodily pain, vitality, and mental health scores improved significantly after treatment (p < 0.001). Depression scores showed no significant difference from baseline to 6 months (p = 0.375).
  
  
  CONCLUSIONS
  The LNG-IUS for the treatment of menorrhagia increases the QoL, and depression scores did not increase significantly in 6 months.
authors.affiliation: Department of Gynecology and Obstetrics, Selcuk University, Konya, Turkey, aybiketzgl@hotmail.com.
authors.forename: Aybike
authors.initials: A
authors.lastname: Tazegül Pekin
authors.forename: Ozlem
authors.initials: O
authors.lastname: Seçilmiş Kerimoğlu
authors.forename: Ayşe Gül
authors.initials: AG
authors.lastname: Kebapcılar
authors.forename: Setenay Arzu
authors.initials: SA
authors.lastname: Yılmaz
authors.forename: Nilgün
authors.initials: N
authors.lastname: Benzer
authors.forename: Cetin
authors.initials: C
authors.lastname: Celik
mesh_terms: D000293:Adolescent; D000328:Adult; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003863:Depression / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000008:administration & dosage*; D008595:Menorrhagia / Q000523:psychology / Q000628:therapy*; D008875:Middle Aged; D011788:Quality of Life; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D003271:Contraceptive Agents, Female; D016912:Levonorgestrel